Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
The Journal of Cell Biology|July 18, 2012
Dynamic remodeling of scaffold interactions in dendritic spines controls synaptic excitabilityEnora Moutin, Fabrice Raynaud, Jonathan Roger, et al.Journal of Cell Science|June 19, 2014
The stoichiometry of scaffold complexes in living neurons - DLC2 functions as a dimerization engine for GKAPEnora Moutin, Vincent Compan, Fabrice Raynaud, et al.Cell Death & Disease|November 28, 2014
SAP97-mediated ADAM10 trafficking from Golgi outposts depends on PKC phosphorylationC Saraceno, E Marcello, D Di Marino, et al.Neurobiology of Disease|February 13, 2018
Seizure progression and inflammatory mediators promote pericytosis and pericyte-microglia clustering at the cerebrovasculatureWendy Klement, Rita Garbelli, Emma Zub, et al.The European Journal of Neuroscience|November 8, 2014
Distinct subsynaptic localization of type 1 metabotropic glutamate receptors at glutamatergic and GABAergic synapses in the rodent cerebellar cortexMahnaz Mansouri, Yu Kasugai, Yugo Fukazawa, et al.Bulletin of Volcanology|April 15, 2024
Tracking magma pathways and surface faulting in the Southwest Rift Zone and the Koa'e fault system (Kīlauea volcano, Hawai 'i) using photogrammetry and structural observationsStefano Mannini, Joël Ruch, Richard W Hazlett, et al.Translational Psychiatry|June 24, 2026
Clinic-to-Mechanism: Unraveling in-depth molecular dysfunctions caused by a GluN2B C-Terminal deletion in developmental and epileptic encephalopathiesRoza Szlendak, Nathalie Bouquier, Sylwia Rzońca-Niewczas, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 26, 2016
Agonist-Specific Recruitment of Arrestin Isoforms Differentially Modify Delta Opioid Receptor FunctionAmynah A Pradhan, Julie Perroy, Wendy M Walwyn, et al.Plos One|November 5, 2016
Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting ProteinsRaphaële Thiébaut, Sophie Esmiol, Patrick Lecine, et al.Cancer Biology & Therapy|September 10, 2009
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumorsNilofer Azad, Alyssa Perroy, Erin Gardner, et al.Pageof 9